Table 3.
The proportion of controlled and uncontrolled BP for patients with hypertension in the MS (JIS criteria) and non-MS groups at baseline and the 1-year follow-up.
| Treatments | MS | Non-MS | P | |||
|---|---|---|---|---|---|---|
| Controlled BP | Uncontrolled BP | Controlled BP | Uncontrolled BP | |||
| Baseline | Drug (%) | 108 (8.44) | 1,171 (91.56) | 65 (27.54) | 171 (72.46) | <0.01 |
| Follow-up | Group one1 (%) | 211 (33.60) | 417 (66.40) | 144 (42.48) | 195 (57.52) | 0.02 |
| Group two2 (%) | 824 (65.09) | 442 (34.91) | 550 (81.00) | 129 (19.00) | <0.01 | |
| Total (%) | 1,035 (54.65) | 859 (45.35) | 694 (68.17) | 323 (31.83) | <0.01 | |
1Only drug therapy, 2Drug + lifestyle intervention therapy.
BP: blood pressure, MS: metabolic syndrome, JIS: the 2009 criteria from the Joint Interim Statement.